Science

Drew Moghanaki: Enough is enough for TACE

gastroclinix.com

Feb 6, 2025, 13:33

Drew Moghanaki: Enough is enough for TACE

Drew Moghanaki, Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA, reshared the post by Yakup Ergün, Medical Oncologist at Antalya City Hospital, on X, adding:

“I trust the day is coming when all MEDICAL ONCOLOGISTS will stand up and say enough is enough for TACE.”

Quoting Yakup Ergün‘s post:

“Meta‐analysis of randomized controlled trials of external‐beam radiation versus TACE for HCC.

Pooled analysis of 3 RCTs.

Compared with TACE, EBRT yields superior local control and PFS early and intermediate stage HCC.”

Drew Moghanaki: Enough is enough for TACE

Meta-analysis of randomized controlled trials of external-beam radiation versus transarterial chemoembolization for hepatocellular carcinoma.

Authors: Ryan A. Kuehnle BS, et al.

Drew Moghanaki: Enough is enough for TACE

Antalya City Hospital cancer Drew Moghanaki EBRT fight against cancer Global fight against cancer HCC hepatocellular carcinoma MedOnc OncoDaily Oncology RadOnc Ryan A. Kuehnle BS TACE transarterial chemoembolization UCLA Yakup Ergün

NEW PAPER ALERT: ESOPEC trial on Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer

Oncologist Near Me - Matti Aapro: Pioneering Excellence in Cancer Care and Geriatric Oncology

World Cancer Day: 25 Years of Global Action and Unity in the Fight Against Cancer

Oncologist Near Me – Giuseppe Curigliano: A Prominent Specialist in Breast Cancer Clinical Trials and Research

FDA Approves T-DXd for HR+, HER2-Low/Ultralow Breast Cancer Treatment